Diseases of the Colon & Rectum

, Volume 44, Issue 1, pp 119–127 | Cite as

Ectopic production of prolactin by colorectal adenocarcinoma

  • Jyotsna M. Bhatavdekar
  • Devendra D. Patel
  • Priya R. Chikhlikar
  • Neelam G. Shah
  • Hemangini H. Vora
  • Nandita Ghosh
  • Trupti I. Trivedi
Original Contributions


PURPOSE: This study assessed the role of prolactin in patients with Dukes B and C colorectal carcinoma. METHODS: Circulating prolactin and carcinoembryonic antigen were assayed using immunoradiometric assay and radioimmunoassay kits, respectively, in preoperative blood (n=98) and tumor-draining venous blood (n=34) samples of colorectal carcinoma patients. Immunohistochemical localization of prolactin (n=98), carcinoembryonic antigen (n=98), and prolactin receptors (n=56) was performed. The expression of prolactin messenger ribonucleic acid (n=50) and prolactin receptor messenger ribonucleic acid (n=50) was studied by reverse transcriptase polymerase chain reaction. Further, prolactin amplimer was sequenced. RESULTS: Preoperative prolactin and carcinoembryonic antigen levels were significantly higher in patients with colorectal carcinoma than in controls (prolactin,P=0.001; carcinoembryonic antigen,P=0.0001). Univariate survival analysis showed that Dukes stage, histologic grade, and circulating prolactin were significant prognostic factors for determining overall survival (Dukes stage,P=0.00001; histologic grade,P=0.005; prolactin,P=0.001). In multivariate analysis, besides Dukes stage, circulating prolactin emerged as the most significant independent prognostic factor influencing overall survival. Preoperative prolactin levels showed excellent significant correlation with response to therapy and progression of disease. A significant tenfold higher mean concentration of prolactin was observed in tumor-draining venous blood than in peripheral blood (P=0.0001). Diffuse cytoplasmic staining for prolactin was seen in 51 percent (50/98) of the colorectal carcinomas. Prolactin messenger ribonucleic acid expression was seen in 88 percent (44/50) of the colorectal carcinomas. Sequence analysis of the 234-bp prolactin amplimer revealed that the sequence was homologous to exon 5 of pituitary prolactin messenger ribonucleic acid. CONCLUSION: These multiple approaches confirmed that prolactin is produced by colorectal carcinoma cells. Looking at its prognostic value and correlation with disease activity, it may provide new insights into treatment for patients with colorectal carcinoma.

Key words

Prolactin Prognosticator Colorectal adenocarcinoma 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Shaw-Bruha CM, Pirrucello SJ, Shull JD. Expression of the prolactin gene in normal and neoplastic human breast tissues and human mammary cell lines: promoter usage and alternative mRNA splicing. Breast Cancer Res Treat 1997;44:243–53.CrossRefPubMedGoogle Scholar
  2. 2.
    Ozarda AT. Prolactin-secreting tumors. J Surg Oncol 1983;22:9–10.PubMedGoogle Scholar
  3. 3.
    Rees LH, Bloomfield GA, Rees GM, Corrin B, Franks LM, Ratcliffe JG. Multiple hormones in a bronchial tumor. J Clin Endocrinol Metab 1974;38:1090–7.PubMedGoogle Scholar
  4. 4.
    Turkington RW. Ectopic production of prolactin. N Engl J Med 1971;285:1455–8.PubMedGoogle Scholar
  5. 5.
    Stanisic TH, Donovan J. Prolactin secreting renal cell carcinoma. J Urol 1986;136:85–6.PubMedGoogle Scholar
  6. 6.
    Hsu C-T, Yu M-H, Gregory Lee C-Y, Jong H-L, Yeh M-Y. Ectopic production of prolactin in uterine cervical carcinoma. Gynecologic Oncol 1992;44:166–71.CrossRefGoogle Scholar
  7. 7.
    Hoffman WH, Gala RR, Kovacs K, Subramanian MG. Ectopic prolactin secretion from a gonadoblastoma. Cancer 1987;60:2690–5.PubMedGoogle Scholar
  8. 8.
    Bhatavdekar JM, Patel DD, Giri DD,et al. Comparison of plasma prolactin and CEA in monitoring patients with adenocarcinoma of colon and rectum. Br J Cancer 1992;66:977–80.PubMedGoogle Scholar
  9. 9.
    Patel DD, Bhatavdekar JM, Ghosh N,et al. Plasma prolactin in patients with colorectal cancer: value in follow-up and as a prognosticator. Cancer 1994;73:570–4.PubMedGoogle Scholar
  10. 10.
    Dukes CE, Bussey HJ. The spread of rectal cancer and its effect on prognosis. Br J Cancer 1958;12:309–20.PubMedGoogle Scholar
  11. 11.
    Morson BC, Sobin LH. International histological classification of tumours. Vol. 15. Geneva: World Health Organization, 1976.Google Scholar
  12. 12.
    Bhatavdekar JM, Patel DD, Ghosh N,et al. Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma. Dis Colon Rectum 1997;40:785–90.CrossRefPubMedGoogle Scholar
  13. 13.
    Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 1987;162:156–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Bhatavdekar JM, Patel DD, Vora HH, Shah NG, Chikhlikar PR, Ghosh N. Prolactin as a local growth promoter in patients with locally advanced tongue cancer: GCRI experience. Head Neck 2000;22:257–64.CrossRefPubMedGoogle Scholar
  15. 15.
    Sambrook J, Fritsch EF, Maniatis T. Analysis and cloning of eukaryotic genomic DNA. In: Nolan C, ed. Molecular cloning—a laboratory manual. New York: Cold Spring Harbor Laboratory Press, 1989:9.1–9.62.Google Scholar
  16. 16.
    Ilan Y, Sibirsky O, Livni N, Gofrit O, Barack V, Goldin E. Plasma and tumor prolactin in colorectal cancer patients. Dig Dis Sci 1995;40:2010–5.CrossRefPubMedGoogle Scholar
  17. 17.
    Molitch ME, Schwartz S, Mukherji B. Is prolactin secreted ectopically? Am J Med 1981;70:803–7.CrossRefPubMedGoogle Scholar
  18. 18.
    Peyrat JP, Djiane J, Bonneterre J,et al. Stimulation of DNA synthesis by prolactin in human breast tumor explants. Relation to prolactin receptors. Anticancer Res 1984;4:257–62.PubMedGoogle Scholar
  19. 19.
    Berwaer M, Martial JA, Davis JR. Characterization of an up-stream promoter directing extrapituitary expression of the human prolactin gene. Mol Endocrinol 1994;8:635–42.CrossRefPubMedGoogle Scholar

Copyright information

© The American Society of Colon and Rectal Surgeons 2001

Authors and Affiliations

  • Jyotsna M. Bhatavdekar
    • 3
    • 2
  • Devendra D. Patel
    • 1
  • Priya R. Chikhlikar
    • 3
  • Neelam G. Shah
    • 3
  • Hemangini H. Vora
    • 3
  • Nandita Ghosh
    • 3
  • Trupti I. Trivedi
    • 3
  1. 1.Department of Cancer BiologyThe Gujarat Cancer and Research InstituteAhmedabadIndia
  2. 2.Speciality Clinics of SurgeryThe Gujarat Cancer and Research InstituteAhmedabadIndia
  3. 3.Division of Molecular Endocrinology, Department of Cancer BiologyThe Gujarat Cancer and Research Institute, NCH CompoundAsarwaIndia

Personalised recommendations